[Henoch-Schönlein purpura following treatment with streptokinase].
This article presents the clinical history of a man aged 64 who developed Henoch-Schönlein purpura after administration of streptokinase for acute myocardial infarction. Because of the increasing use of streptokinase it is assumed that type III hypersensitivity reactions to streptokinase will be seen more frequently. The first symptoms may arise after discharge from the hospital, as symptom-free periods of 3 to 21 days have been reported.
Stam
F
F
Afd. Inwendige Geneeskunde, Academisch Ziekenhuis Vrije Universiteit, Amsterdam.
Stehouwer
C D
CD
D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D013300:Streptokinase / Q000009:adverse effects* / Q000627:therapeutic use
D013300:Streptokinase
Henoch-Schönlein-purpura na behandeling met streptokinase.